The A1C test CPT code seems to be the easiest line on a lab claim. One code, one outcome. But that simplicity is also why mistakes go unnoticed until the denials start to pile up and by then the same mistake has been repeated for hundreds of patient visits. In this guide we’ll go through the code itself, the 83036/83037 split, Medicare and commercial rules, ICD-10 pairing, the QW modifier, documentation, and the most common denial patterns we see. The work of coders at A2Z Billings, a Michigan billing company boasting a 98% first-pass clean claims rate.
What CPT 83036 Reports
The CPT code for glycosylated haemoglobin (A1c) is 83036. It shows what percentage of haemoglobin has glucose attached to it and provides an overview of your average blood sugar levels over the last three months. The CMS coverage determination stated that laboratories typically tested for it with ion-exchange chromatography, immunoassay, or gel electrophoresis. The code remains consistent regardless of the method used. A quantitative result counts as one unit.
The American Diabetes Association rates the number as clinically significant. If your reading is 6.5% or higher, it indicates that you have diabetes. If your reading falls between 5.7% and 6.4%, you have prediabetes. The ADA's Standards of Care in Diabetes recommends testing at least every 6 months for patients who are meeting treatment goals and every 3 months for those who are not meeting goals or have recently changed therapies. Payers use those intervals to determine frequency edits, so billers must be aware of them.
CPT 83036 vs 83037
CPT 83037 describes the same test run on a device the FDA has cleared for home use. The 83036 descriptor does not identify a testing location. Point of service testing is permitted as per the CMS decision memo for NCD 190.21. It’s up to the analyst to code. If the device is FDA cleared for use in the home, bill 83037. If not, charge 83036.
A clinic purchases a point-of-care analyser, and the front desk continues to bill 83036 as a matter of routine. Mistakes occur. Nobody opens the clearance papers. Save the analyser model and the clearance status in the lab’s equipment file so the coder has something to check each time.
Medicare and Commercial Coverage Rules
Medicare covers glycated hemoglobin testing under NCD 190.21, implemented on January 1, 2003. There is no national frequency limit to the NCD, according to published coding guides. It connects testing to clinical need and views the A1C as a test to monitor those already diagnosed with diabetes. Medicare administrative contractors add their own diagnosis edits via local coverage articles, so a claim allowed in one jurisdiction could be denied in another.
Commercial and Medicaid plans tend to be more restrictive. UnitedHealthcare Community Plan will only reimburse for A1C testing for the diagnosis of type 1 or type 2 diabetes and only once every three months. Other payers have their own windows to publish. Pull each major payer’s policy and build the window into the billing system as a flag so a test billed 60 days after the last one gets reviewed prior to submission instead of after denial.
Practices that manage large diabetic panels, such as internal medicine and family practice groups, repeat any coding error at every quarterly visit. Nephrology practitioners see the same pattern with diabetic kidney disease patients.
ICD-10 Pairing for Medical Necessity
Each A1C claim must include a diagnosis to support the reason for ordering the test. For established diabetes this is a code from the E10 or E11 family, for example, E11.9 for type 2 diabetes without complications or E11.65 for type 2 with hyperglycaemia. Z79.4 long-term (current) use of insulin Z79.84 long-term (current) use of oral hypoglycemic These are secondary codes that support the need for frequent testing. R73.03 is prediabetes. Z13.1 is screening for diabetes.
Claims are dropped in screening. The A1C is often viewed by payers as a monitoring test, so a screening claim for a patient without a diagnosis of diabetes may not be on the covered services list. Verify the payer's policy and then send the order out. Document the reason given by the provider. If you pick a diagnosis just to be able to do an edit, that’s a compliance issue, and that’s what auditors are looking for.
When to Use the Modifier 'QW'
Modifier QW tells the payer that the test ran on a CLIA-waived analyzer. It applies when the practice holds a CLIA certificate of waiver and uses a waived device, so the claim line reads 83036 QW. Medicare also expects the CLIA number on the claim.
QW stays off the claim in two cases. A lab with a certificate of compliance or accreditation does not bill with it, and a reference lab that bills under its own CLI A number does not use it either. Payers verify the claim. A QW on the wrong claim leads to a recoupment request, just as a missing QW leads to a denial. Match the modifier to the certificate the lab actually has and keep a copy of that certificate in the billing file.
Documentation That Holds Up in an Audit
Auditors read the chart before they read the claim. A defensible A1C record holds six items: the provider’s order, the diagnosis or symptom that prompted it, the collection date, the method or analyzer with its CLIA status, the result as a percentage, and proof that the provider reviewed the result and acted on it.
The last item gets skipped most often. A result sitting in the lab system with no sign-off or plan note does not show medical necessity, and it is the first thing a reviewer asks about. A note as short as “A1C 8.4%, increase metformin, recheck in 3 months” does the job.
Bill the blood draw separately when it is applicable. CPT 36415 covers venipuncture. The fingerstick collection uses a different code, 36416, and many payers bundle it. When the same visit includes a separately documented evaluation and management service, the E/M line may need modifier 25, which the office visit CPT codes guide explains in detail.
Quality Reporting Codes
A1C results also support quality programmes. CPT Category II codes report the result range without payment: 3044F below 7.0%, 3051F 7.0% to below 8.0%, 3052F 8.0% to 9.0%, and 3046F above 9.0%. The MIPS diabetes control measure uses the 9.0% line. Some current specifications use M-codes instead, e.g., M1211 for results >9.0%. So be sure to check the measure specification for the reporting year before loading codes into the billing system. If you’re missing a quality code, you’re missing revenue. That’s because MIPS scores drive Medicare payment adjustments.
Why A1C Claims Get Denied
Four patterns come up repeatedly in A1C denials.
The first is medical necessity, usually returned as CO-50. The diagnosis is missing, sits outside the payer’s covered list, or reports screening for a patient the plan does not cover. Palmetto GBA’s guidance on this denial says that when the patient signed a valid ABN before the test, the claim went out with modifier GA. Without the ABN, the provider absorbs the cost.
The second is frequency, which often comes back as CO-151. The test fell inside the payer’s window. First confirm the previous date of service. If the second test was warranted, appeal with a progress note showing poor control or medication change.
Third, there is a modifier or CLIA issue: a missing QW on a waived test, a QW on a test performed under a certificate of compliance, or a CLIA number that does not match the performing lab.
The fourth is the 83036 and 83037 mix-up described earlier. It is a coding error, and the fix is a corrected claim with the right code.
A pre-submission coding and documentation check catches these errors before the payer does. When a denial does come back, rejected claim review pulls the exact denial code, fixes the cause, and resubmits. Practices that want to review their medical coding patterns can start with a single payer and a single month of A1C claims.
Frequently Asked Questions
What is the CPT code for an A1C test?
CPT 83036 reports hemoglobin, glycosylated (A1C). CPT 83037 reports the same test on a device cleared by the FDA for home use. The analyzer’s clearance status decides which code applies.
Does an A1C test need modifier QW?
Only when the test runs on a CLIA-waived analyzer under a certificate of waiver. Labs with a certificate of compliance or accreditation bill without it and reference labs billing under their own CLIA number leave it off too.
How often can an A1C test be billed?
It depends on the payer. NCD 190.21 sets no hard national cap. According to published coding guides, the UnitedHealthcare Community Plan pays once every three months for diabetes diagnoses, and the ADA recommends two to four tests a year based on control. Check each payer’s policy.
What ICD-10 codes support an A1C claim?
Established diabetes uses E10 or E11 families, such as E11.9 or E11.65. Use the prediabetes code R73.03 and the screening code Z13.1, if the payer allows. Z79.4 and Z79.84 are for insulin or oral medication for long-term use.
Is it possible to bill an A1C test on the same day as a metabolic panel?
Yes, most of the time. Each test has its own code, and panels like 80053 and 80048 are on different lines. If the claim denies: 1. Check diagnosis pairing and QW modifier.
What should a lab do after a medical necessity denial?
Confirm the diagnosis on the claim matches the order. For Medicare, check whether a valid ABN was signed and, if so, resubmit with modifier GA. Otherwise, appeal with the order, the result, and the provider’s note.
Get Your A1C Claims Paid the First Time.
When an A1C claim is denied, it takes staff time to rework it, and the same errors keep happening. A2Z Billings takes care of it at the source. Each account has a dedicated coder that learns your payer mix and denial patterns, so the longer the work runs, the faster you get corrections. Rejected claim corrections are mailed within 3 business days, and the first-pass clean claims rate is 98%.
Pricing is simple. Medical billing plans start at 3% of monthly collections. No long-term contract. Solo practices with collections under $15,000 pay a flat fee of $500. The audit and consultation are free and will pinpoint exactly where your revenue leaks are right now.
Book your free audit or talk to a billing expert to find out what your A1C claims are missing.